HeartPoint Global
@heartpointglobal.com
As a pioneer of breakthrough medical solutions, HeartPoint Global (HPG) is paving the way for citizens worldwide to receive affordable, cutting-edge cardiac care. In response to the 92 percent of the world’s population has no access to cardiac surgery, the leading medical device company is on a mission to provide innovative, minimally invasive, and accessible cardiac care on a global scale to ensure those who would otherwise suffer from or die of cardiovascular disease receive the care they need. HPG’s patented Implant System (HPGS) is the first and only patented non-surgical structural heart system that addresses a variety of serious, life-threatening cardiovascular diseases. An estimated 17.9 million died from cardiovascular diseases in 2016, representing 31 percent of global deaths. Of those, more than 75 percent of cardiovascular disease deaths take place in the developing world, where treatments are either not available or are far too expensive. The HPGS allows for the adjustment of blood flow and pressure during and after placement in the main pulmonary artery and/or its branches in order to restore the structure of the heart-lung system. The investigational device’s pre-clinical trials are ongoing, and clinical trials will soon begin in Europe. Once approved for public use, this life saving device will be distributed in both the developing and developed worlds, with an immediate focus on patients who do not have access to cardiac care. HeartPoint Global is a privately held American company with operations in the USA, Ireland, and Israel.
HeartPoint Global's Company Logos
HeartPoint Global's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#C00017
Monza
192, 0, 23
353, 100, 38
0, 100, 88, 25
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#61A229
Olive Drab
97, 162, 41
92, 60, 40
40, 0, 75, 36
About HeartPoint Global
HeartPoint Global Inc. is an innovative healthcare brand that is committed to reducing inequality in cardiovascular health worldwide. With a focus on affordability and accessibility, they provide patented, safer, and more affordable solutions that aim to revolutionize cardiovascular treatment.
Their groundbreaking product, the HeartPoint Global Implant System (HPGS), is a first-of-its-kind minimally invasive adjustable structural heart system. It offers solutions for a wide range of cardiovascular diseases, including congenital heart defects and congestive heart disease. The HPGS not only reduces recovery times and potential complications but also improves cardiac function and quality of life for patients.
With a serviceable obtainable market of 34 million people, HeartPoint Global Inc. is dedicated to bringing hope and saving lives. Led by a visionary founding team and renowned medical experts, they are making significant strides in cardiovascular health.
Get in touch with HeartPoint Global Inc. to learn more about their life-changing solutions
